Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

FDA approves label update for Prezista

Oct. 24, 2011

Purdue Research Foundation discovers new chemokine CCR5 receptor antagonists

Oct. 17, 2011

New clinical data presented on novel HIV integrase inhibitor

Oct. 17, 2011

Gilead obtains worldwide rights for novel HIV integrase inhibitors from Boehringer Ingelheim

Oct. 6, 2011

HIV-1 DNA/MVA-CMDR prime-boost vaccination evaluated in two clinical studies

Oct. 6, 2011

Enrollment completed in GeoVax's HIV/AIDS vaccine study

Oct. 4, 2011

Microbicide Trials Network to discontinue use of tenofovir tablets in HIV prevention study

Oct. 3, 2011

Multifunctional fusion protein prevents HIV infection in vivo

Sep. 30, 2011

Ibalizumab shows promise in phase IIb study

Sep. 30, 2011

Novel agents show promise against raltegravir-resistant HIV

Sep. 30, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...